DHR250502P148000
- 0.01
- 0.000.00%
Danaher Newsroom
Danaher Insider Sold Shares Worth $3,129,424, According to a Recent SEC Filing
Danaher Corporation (DHR): Among Charles Akre's and John Neff's Stock Picks With Huge Upside Potential
Kytopen And Aldevron Announce Joint Marketing Agreement To Enhance Workflow Solutions For Cell Therapy Manufacturers
Jim Cramer on Danaher Corporation (DHR): From Best to Worst Amid China Struggles
Live Cell Imaging Market Worth US$4.75 Billion in 2030 With 8.68% CAGR | MarketsandMarkets
Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus
Market Whales and Their Recent Bets on DHR Options
Should You Investigate Danaher Corporation (NYSE:DHR) At US$197?
New Analyst Forecast: $DHR Given $240.0 Price Target
Express News | Danaher Corporation : HSBC Cuts Target Price to $240 From $270
Scotiabank Maintains Danaher(DHR.US) With Hold Rating, Maintains Target Price $265
Express News | Form 144 | Danaher(DHR.US) Insider Proposes to Sell 117.56 Million in Common Stocks
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
How Is The Market Feeling About Danaher?
A Quick Look at Today's Ratings for Danaher(DHR.US), With a Forecast Between $210 to $265
Analyst Sees Opportunity In Danaher Stock As Sentiment Improves
Express News | RBC Capital Reiterates Outperform on Danaher, Maintains $250 Price Target
Express News | Goldman Sachs Maintains Buy on Danaher, Lowers Price Target to $240
Danaher Corporation (DHR): Among Top Stocks in Bill Gates' Portfolio With Huge Upside Potential
Danaher Price Target Maintained With a $250.00/Share by Guggenheim